Amgen Inc. (AMGN) Sector
Health Care

(Current) $305.84
-0.58 (-0.19%) Open Price: 306.50

Amgen Inc. is a renowned biotechnology company with a rich history of groundbreaking scientific advancements and innovations in the field of healthcare. Founded in April 1980 by William K. Bowes Jr., Amgen has become a global leader in developing and manufacturing innovative therapies for serious illnesses. The company's name, "Amgen," is derived from the amalgamation of the words "Applied Molecular Genetics."

Amgen's primary focus is on the discovery, development, and commercialization of biopharmaceutical products aimed at treating various medical conditions, including cancer, cardiovascular disease, inflammatory disorders, and more. The company is particularly recognized for its contributions to biotechnology through the development of novel therapies and the use of recombinant DNA technology to produce therapeutic proteins.

Listed on the NASDAQ stock exchange under the ticker symbol "AMGN," Amgen has achieved consistent financial success due to its robust product portfolio and commitment to research and development. The company has a diversified product pipeline that includes both innovative new drugs and established treatments for a range of medical conditions.

Amgen's most well-known drugs include Enbrel, which is used to treat autoimmune disorders like rheumatoid arthritis, and Neulasta, a medication that reduces the risk of infection in patients undergoing chemotherapy. The company's innovations have significantly impacted patient care and the medical community by providing effective treatment options and improving quality of life.

An additional noteworthy aspect of Amgen's operations is its focus on partnerships and collaborations. The company has worked with various academic institutions, research organizations, and biotechnology companies to advance its research efforts and bring new therapies to market. This collaborative approach has played a vital role in accelerating the development of innovative medical solutions.

With its emphasis on scientific excellence, Amgen continues to be at the forefront of biotechnology and pharmaceutical innovation. The company's dedication to improving patient outcomes and its history of pioneering discoveries highlight its significance within the global healthcare landscape.

(05/23/24) $306.50
(05/25/24) $306.42
(05/25/24) (Qty.)2,395,184
(05/23/24) $304.38
(05/23/24) $311.99
(05/05/24) $297.52
(05/12/24) $321.44
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing